Other
Homeostasis
0
Pipeline Programs↗
2
Active Trials↗
3
Companies Involved↗
Homeostasis is an early-stage landscape with 0 programs across 3 companies. The most active players are Idorsia Pharmaceuticals Ltd., Takeda, Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
28
clinical trials
Completed20 · 71%
Terminated2 · 7%
Unknown status2 · 7%
Not yet recruiting1 · 4%
Recruiting1 · 4%
Withdrawn1 · 4%
Other1 · 4%
Clinical Trials
Trial Activity
28 trials
The Effects of N-acetylcysteine on Performance and Redox Homeostasis
Completed·—·Phase 2·NCT03121222·36 enrolled
Extragonadal Effects of hCG on Calcium Homeostasis
Completed·—·Phase 1·NCT03418896·12 enrolled
Tolerance by Engaging Antigen During Cellular Homeostasis
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT03504241·8 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)